As a subsequence to the DNA damage and alteration during the initiation of CML, phosphorylation of MDM2 protein will occur, which stops the inhibitory effect of MDM2 protein on the p53 gene activation. This evidence concerns the gene MDM2 and chronic myelogenous leukemia, BCR-ABL1 positive.